Rankings
▼
Calendar
ONC Q3 2025 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena
ONC
BeOne Medicines Ltd.
$33B
Q3 2025 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$1.4B
+41.0% YoY
Gross Profit
$1.2B
86.1% margin
Operating Income
$163M
11.5% margin
Net Income
$125M
8.8% margin
EPS (Diluted)
$13.52
QoQ Revenue Growth
+7.4%
Cash Flow
Operating Cash Flow
$403M
Free Cash Flow
$354M
Stock-Based Comp.
$141M
Balance Sheet
Total Assets
$7.6B
Total Liabilities
$3.5B
Stockholders' Equity
$4.1B
Cash & Equivalents
$4.0B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.4B
$1.0B
+41.0%
Gross Profit
$1.2B
$831M
+46.3%
Operating Income
$163M
-$120M
+235.6%
Net Income
$125M
-$121M
+202.9%
Revenue Segments
Product
$1.8B
100%
Geographic Segments
UNITED STATES
$755M
53%
CHINA
$440M
31%
Europe
$167M
12%
All Other Countries Except China And United States Of America
$51M
4%
← FY 2025
All Quarters
Q4 2025 →